LLY•benzinga•
Reported Earlier, Zepbound (Tirzepatide) Outperforms Wegovy In Head-To-Head Study, Delivering Over 20% Average Weight Loss Over 72 Weeks
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 12, 2025 by benzinga